Evidence map›Paper›PMID 42163850›Full record

ArticleJTO clinical and research reports2026

Corrigendum to 'Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes' [JTO Clinical and Research Reports 6 (2025) 100914].

Surbhi Singhal, Caressa Hui, Joel W Neal, Seema Nagpal, Mohana Roy, Millie Das, Kavitha Ramchandran, Erqi Pollom, Giovanni Selvaggi, Heather A Wakelee and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Surbhi SinghalDivision of Hematology/Oncology, Department of Medicine, University of California Davis, Sacramento, California.
Caressa HuiDepartment of Radiation Oncology, University of California Irvine, Irvine, California.
Joel W NealDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.
Seema NagpalDepartment of Neurology, Stanford University, Stanford, California.
Mohana RoyDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.
Millie DasDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.
Kavitha RamchandranDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.
Erqi PollomDepartment of Radiation Oncology, Stanford University, Stanford, California.
Giovanni SelvaggiXcovery Holdings Inc., Miami, Florida.
Heather A WakeleeDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.
Nathaniel J MyallDivision of Medical Oncology, Department of Medicine, Stanford University, Stanford, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.jtocrr.2025.100914.].

Identifiers

PMID42163850
PMCPMC13185977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.